BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 11685469)

  • 1. The DNA-binding ability of HIVEP3/KRC decreases upon activation of V(D)J recombination.
    Wu LC; Hicar MD; Hong J; Allen CE
    Immunogenetics; 2001 Sep; 53(7):564-71. PubMed ID: 11685469
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Embryonic expression and regulation of the large zinc finger protein KRC.
    Hicar MD; Robinson ML; Wu LC
    Genesis; 2002 May; 33(1):8-20. PubMed ID: 12001065
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The kappa B transcriptional enhancer motif and signal sequences of V(D)J recombination are targets for the zinc finger protein HIVEP3/KRC: a site selection amplification binding study.
    Allen CE; Mak CH; Wu LC
    BMC Immunol; 2002 Aug; 3():10. PubMed ID: 12193271
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Developmental anomalies and neoplasia in animals and cells deficient in the large zinc finger protein KRC.
    Allen CE; Muthusamy N; Weisbrode SE; Hong JW; Wu LC
    Genes Chromosomes Cancer; 2002 Dec; 35(4):287-98. PubMed ID: 12378523
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The roles of the RAG1 and RAG2 "non-core" regions in V(D)J recombination and lymphocyte development.
    Jones JM; Simkus C
    Arch Immunol Ther Exp (Warsz); 2009; 57(2):105-16. PubMed ID: 19333736
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The bounty of RAGs: recombination signal complexes and reaction outcomes.
    Swanson PC
    Immunol Rev; 2004 Aug; 200():90-114. PubMed ID: 15242399
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The taming of a transposon: V(D)J recombination and the immune system.
    Jones JM; Gellert M
    Immunol Rev; 2004 Aug; 200():233-48. PubMed ID: 15242409
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation by phosphorylation of the zinc finger protein KRC that binds the kappaB motif and V(D)J recombination signal sequences.
    Bachmeyer C; Mak CH; Yu CY; Wu LC
    Nucleic Acids Res; 1999 Jan; 27(2):643-8. PubMed ID: 9862992
    [TBL] [Abstract][Full Text] [Related]  

  • 9. V(D)J targeting mistakes occur at low frequency in acute lymphoblastic leukemia.
    Vanura K; Vrsalovic MM; Le T; Marculescu R; Kusec R; Jäger U; Nadel B
    Genes Chromosomes Cancer; 2009 Aug; 48(8):725-36. PubMed ID: 19455608
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modulation of RAG/DNA complex by HSP70 in V(D)J recombination.
    Son YM; Lee JH; Kim DR
    Biochem Biophys Res Commun; 2008 Jan; 365(1):113-7. PubMed ID: 17980153
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression and reexpression of recombination activating genes: relevance to the development of autoimmune states.
    Hillion S; Rochas C; Youinou P; Jamin C
    Ann N Y Acad Sci; 2005 Jun; 1050():10-8. PubMed ID: 16014516
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative analyses of sheep and human TRG joining regions: evolution of J genes in Bovidae is driven by sequence conservation in their promoters for germline transcription.
    Miccoli MC; Vaccarelli G; Lanave C; Cribiu EP; Ciccarese S
    Gene; 2005 Aug; 355():67-78. PubMed ID: 16039073
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The kappaB and V(D)J recombination signal sequence binding protein KRC regulates transcription of the mouse metastasis-associated gene S100A4/mts1.
    Hjelmsoe I; Allen CE; Cohn MA; Tulchinsky EM; Wu LC
    J Biol Chem; 2000 Jan; 275(2):913-20. PubMed ID: 10625627
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of the proximal enhancer element and transcriptional regulatory factors for murine recombination activating gene-2.
    Wei XC; Dohkan J; Kishi H; Wu CX; Kondo S; Muraguchi A
    Eur J Immunol; 2005 Feb; 35(2):612-21. PubMed ID: 15657951
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Involvement of illegitimate V(D)J recombination or microhomology-mediated nonhomologous end-joining in the formation of intragenic deletions of the Notch1 gene in mouse thymic lymphomas.
    Tsuji H; Ishii-Ohba H; Katsube T; Ukai H; Aizawa S; Doi M; Hioki K; Ogiu T
    Cancer Res; 2004 Dec; 64(24):8882-90. PubMed ID: 15604248
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Accessibility control of V(D)J recombination.
    Cobb RM; Oestreich KJ; Osipovich OA; Oltz EM
    Adv Immunol; 2006; 91():45-109. PubMed ID: 16938538
    [TBL] [Abstract][Full Text] [Related]  

  • 17. B-cell repertoire formation: role of the recombination signal sequence in non-random V segment utilization.
    Feeney AJ; Tang A; Ogwaro KM
    Immunol Rev; 2000 Jun; 175():59-69. PubMed ID: 10933591
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A short peptide at the C terminus is responsible for the nuclear localization of RAG2.
    Corneo B; Benmerah A; Villartay JP
    Eur J Immunol; 2002 Jul; 32(7):2068-73. PubMed ID: 12115628
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Central and peripheral RAG protein re-expression: underestimate mechanisms of tolerance?
    Hillion S; Rochas C; Devauchelle V; Youinou P; Jamin C
    Scand J Immunol; 2006 Sep; 64(3):185-9. PubMed ID: 16918685
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DNA sequence analysis of interlocus recombination between the human T-cell receptor gamma variable (GV) and beta diversity-joining (BD/BJ) sequences on chromosome 7 (inversion 7).
    Ballinger SW; Judice SA; Nicklas JA; Albertini RJ; O'Neill JP
    Environ Mol Mutagen; 2002; 40(2):85-92. PubMed ID: 12203400
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.